Sciencast Management’s Cellebrite CLBT Stock Holding History

Sciencast Management’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,526	Closed	-$228K	–	271
2026 Q1	$228K	Buy	+16,526	New	+$249K	0.03%	236

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Sciencast Management's CLBT Position: Q2 2026 in Review

Sciencast Management sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 16,526 shares — an estimated $228K sold.

Sciencast Management first reported a position in CLBT in Q1 2026 and held it in 1 quarter. The position peaked at $228K in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Sciencast Management reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
Sciencast Management sold 16,526 Cellebrite shares in Q2 2026, an estimated $228K.
Sciencast Management first reported a position in Cellebrite in Q1 2026 and held it in 1 quarter.
Sciencast Management's Cellebrite position peaked at $228K in Q1 2026.
201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Sciencast Management's 13F filing for Q2 2026, filed 28 Jul 2026.